In:
Polish Journal of Surgery, Index Copernicus, Vol. 92, No. 4 ( 2020-5-18), p. 47-53
Abstract:
Surgical interventions in patients with peritoneal metastases combined with hyperthermic intraperitoneal chemotherapy
(HIPEC) and systemic treatment are becoming more common and, when applied to selected patient groups, they reach 5-year survival rates of 32–52%. Good clinical outcomes require experienced and well-equipped healthcare centers, experienced
surgical team and adequate patient qualification process. As a result of the discussion on the need for evaluation of quality of care and treatment outcomes and at the request of the Peritoneal Cancer Section of the Polish Society of Surgical Oncology,
accreditation standards have been developed and the Accreditation Committee has been established for healthcare centers providing cytoreductive surgery and HIPEC for the management of primary and secondary peritoneal cancers.
Type of Medium:
Online Resource
ISSN:
0032-373X
,
2299-2847
DOI:
10.5604/01.3001.0014.1476
Language:
English
Publisher:
Index Copernicus
Publication Date:
2020
detail.hit.zdb_id:
2406095-1